Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Hallifax, et al. Reply to Albert and to Dhooria, et al.

Hallifax RJ. et al, (2022), American Journal of Respiratory and Critical Care Medicine

Cost-effectiveness of ambulatory care management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.

Luengo-Fernandez R. et al, (2022), Thorax, 77, 913 - 918

Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the United Kingdom (POETIC) survey.

Melhorn J. et al, (2022), The European respiratory journal

Challenging the Paradigm of Persistent Air Leak: Are We Prolonging the Problem?

Walker SP. et al, (2022), American journal of respiratory and critical care medicine

Pneumothorax management: current state of practice in the UK.

Hallifax RJ. et al, (2022), Respiratory research, 23

Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial

Psallidas I. et al, (2022), The Lancet Respiratory Medicine, 10, 139 - 148

Aetiology of Primary Spontaneous Pneumothorax.

Hallifax R., (2022), Journal of clinical medicine, 11

A randomised controlled trial of intrapleural balloon intercostal chest drains to prevent drain displacement

Mercer RM. et al, (2021), European Respiratory Journal, 2101753 - 2101753

Management of primary spontaneous pneumothorax: less is more - Authors' reply.

Hallifax RJ. et al, (2021), Lancet (London, England), 396, 1973 - 1974

Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant

Turnbull CD. et al, (2021), BMJ Open Respiratory Research, 8, e001044 - e001044

Ambulatory management of secondary spontaneous pneumothorax: a randomised controlled trial.

Walker SP. et al, (2021), The European respiratory journal, 57

Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments

Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008

European Respiratory Society Statement on Thoracic Ultrasound.

Laursen CB. et al, (2020), The European respiratory journal

Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experience

Hallifax RJ. et al, (2020), BMJ Open Respiratory Research, 7, e000678 - e000678

Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.

Hallifax RJ. et al, (2020), Lancet (London, England), 396, 39 - 49

Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set

Mercer RM. et al, (2020), Respirology, 25, 750 - 755

Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis.

Mercer RM. et al, (2020), ERJ open research, 6

Intercostal vessel screening prior to pleural interventions by the respiratory physician: a prospective study of real world practice

Bedawi EO. et al, (2020), European Respiratory Journal, 55, 1902245 - 1902245

Pneumothorax-Time for New Guidelines?

Hallifax R. and Janssen JP., (2019), Seminars in respiratory and critical care medicine, 40, 314 - 322

Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial

Hallifax R. et al, (2019), BMJ Open Respiratory Research, 6, e000403 - e000403

Load More

1
2
3
4
5

Include forthcoming?